Cargando…

Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response

Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kissick, Haydn T., Sanda, Martin G., Dunn, Laura K., Arredouani, Mohamed S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972205/ https://www.ncbi.nlm.nih.gov/pubmed/24690990 http://dx.doi.org/10.1371/journal.pone.0093231

Ejemplares similares

PTP1B regulates lymphocytes responses androgen deprivation
por: Arredouani, Simo, et al.
Publicado: (2014)

Modulation of CD8(+) T cell responses to AAV vectors with IgG-derived MHC class II epitopes
por: Hui, Daniel J, et al.
Publicado: (2013)

MHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4(+) T Cells with Apoptosis-Inducing Properties
por: Malek Abrahimians, Elin, et al.
Publicado: (2015)

Generation of tumor antigen-specific CD4+ and CD8+ T cells by simultaneous MHC-I and -II epitope presentation in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2014)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
por: James, Eddie A., et al.
Publicado: (2009)

CD8(+) T-cell cross-competition is governed by peptide–MHC class I stability
por: Galea, Ian, et al.
Publicado: (2012)

Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination
por: Datta, Jashodeep, et al.
Publicado: (2014)

A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis
por: Rai, Pradeep K., et al.
Publicado: (2018)

Enhanced Detection of Antigen-Specific CD4(+) T Cells Using Altered Peptide Flanking Residue Peptide–MHC Class II Multimers
por: Holland, Christopher J., et al.
Publicado: (2015)

The CD8 Population in CD4-deficient Mice Is Heavily Contaminated with MHC Class II–restricted T Cells
por: Tyznik, Aaron J., et al.
Publicado: (2004)

Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes
por: Schmidt, Julien, et al.
Publicado: (2013)

Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
por: Leung, Carol S. K.
Publicado: (2015)

Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects
por: Hamrouni, Sarra, et al.
Publicado: (2020)

Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses
por: Pata, Supansa, et al.
Publicado: (2011)

In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4(+) T Cells in Tissues
por: Dileepan, Thamotharampillai, et al.
Publicado: (2015)

Enhanced Vaccine-Induced CD8(+) T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain
por: Spencer, Alexandra J., et al.
Publicado: (2014)

Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4(+) T-cells
por: Simhadri, Vijaya L., et al.
Publicado: (2021)

MHC Class I-Restricted Myelin Epitopes Are Cross-Presented by Tip-DCs That Promote Determinant Spreading to CD8(+) T Cells
por: Ji, Qingyong, et al.
Publicado: (2013)

An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II–restricted T cells in the absence of CD4
por: Kao, Henry, et al.
Publicado: (2005)

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region
por: Wooldridge, Linda, et al.
Publicado: (2007)

MHC Class II Expression Restricted to CD8α(+) and CD11b(+) Dendritic Cells Is Sufficient for Control of Leishmania major
por: Lemos, Maria P., et al.
Publicado: (2004)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Detection of Foreign Antigen-specific CD4(+)Foxp3(+) Regulatory T Cells by MHC Class II Tetramer and Intracellular CD154 Staining
por: Choi, Jin Young, et al.
Publicado: (2013)

The Role of the Transcription Factor SIM2 in Prostate Cancer
por: Lu, Bin, et al.
Publicado: (2011)

Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis
por: Dikhit, Manas Ranjan, et al.
Publicado: (2017)

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers
por: Poluektov, Yuri, et al.
Publicado: (2021)

High expression of CD38 and MHC class II on CD8(+) T cells during severe influenza disease reflects bystander activation and trogocytosis
por: Jia, Xiaoxiao, et al.
Publicado: (2021)

The TCR’s sensitivity to self-peptide–MHC dictates the ability of naïve CD8(+) T cells to respond to foreign antigens
por: Fulton, Ross B., et al.
Publicado: (2014)

Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.
por: Norazmi, M. N., et al.
Publicado: (1989)

Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments
por: Michel, R B, et al.
Publicado: (2004)

A novel Minimalist Cell-Free MHC Class II Antigen Processing System Identifies Immunodominant Epitopes
por: Hartman, Isamu Z., et al.
Publicado: (2010)

The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability
por: Lazarski, Christopher A., et al.
Publicado: (2006)

Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4(+) CTL
por: Hegde, Nagendra R., et al.
Publicado: (2005)

Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough
por: Holland, Christopher J., et al.
Publicado: (2013)

MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015)

Proteolysis and antigen presentation by MHC class II molecules
por: Bryant, Paula Wolf, et al.
Publicado: (2002)

Translation is actively regulated during effector CD8(+) T cell differentiation
por: Araki, Koichi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a4ku2gkuvk4pkm67md7nqr457q